The Agency for Healthcare Research and Quality is looking more closely at why some patients diagnosed with depression don’t respond to treatment. Currently, there is scant data on the prevalence of treatment-resistant depression, and a thorough review of the research that exists hasn’t been conducted. So AHRQ is embarking on a review of both ongoing and published studies of treatment-resistant depression. Specifically, they’re looking at how the condition is defined, what populations have been studied, and which drugs have been tested.
Have a study you’d like to submit? Do so here by March 31, 2017.